Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 16/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18012784 | 0.88 | RAB9A (0.41) | PDK2ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL18673351 | 0.87 | ALK (0.36) | ALKPDK2ALDH1A1MAPTRAB9A | |
| SCHEMBL19186394 | 0.82 | ALK (0.44) | ALKPDK2MAPTRAB9A | |
| SCHEMBL17877630 | 0.79 | PDK2 (0.48) | PDK2ALDH1A1MAPTSMN1; SMN2L3MBTL1 | |
| SCHEMBL17257396 | 0.78 | NPC1 (0.50) | ALDH1A1MAPTRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL17257448 | 0.78 | NPC1 (0.50) | ALDH1A1MAPTRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL17257474 | 0.76 | GSK3B (0.49) | MAPTRAB9ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL17257476 | 0.76 | GSK3B (0.49) | MAPTRAB9ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL18852824 | 0.75 | ALDH1A1 (0.39) | PDK2ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL18012799 | 0.75 | MAPT (0.40) | PDK2MAPTRAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351526-B2 | Coloring curable resin composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, image display device, compound, and cation | FUJIFILM CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-9720319-B2 | Colored composition, cured film, color filter, method for manufacturing color filter, solid-state imaging element, image display device, and compound | FUJIFILM CORPORATION (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9605154-B2 | Curable coloring composition, cured film, color filter, method for manufacturing color filter, solid-state image pickup element, picture display device, and triarylmethane compound | FUJIFILM CORPORATION (JP) | 2017-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351526-B2 | Coloring curable resin composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, image display device, compound, and cation | O60361, WDR12, SEM1 | ALK 2863/4885PDK2 4846/4885ALDH1A1 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.